MDPL.F Stock Overview
A biotech/life sciences company, focuses on the development of a drug delivery system using novel dissolvable microneedle arrays for the treatment of certain skin cancers.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Medicus Pharma Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$1.65 |
| 52 Week High | CA$2.94 |
| 52 Week Low | CA$1.65 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | -17.50% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -38.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| MDPL.F | US Biotechs | US Market | |
|---|---|---|---|
| 7D | 0% | -0.009% | 0.5% |
| 1Y | n/a | 9.8% | 23.9% |
Return vs Industry: Insufficient data to determine how MDPL.F performed against the US Biotechs industry.
Return vs Market: Insufficient data to determine how MDPL.F performed against the US Market.
Price Volatility
| MDPL.F volatility | |
|---|---|
| MDPL.F Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 10.5% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.4% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: MDPL.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine MDPL.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2015 | n/a | Raza Bokhari | medicuspharma.com |
Medicus Pharma Ltd., a biotech/life sciences company, focuses on the development of a drug delivery system using novel dissolvable microneedle arrays for the treatment of certain skin cancers. It intends to develop SkinJect to non-invasively treat basal cell carcinoma of the skin. The company was founded in 2015 and is headquartered in Toronto, Canada.
Medicus Pharma Ltd. Fundamentals Summary
| MDPL.F fundamental statistics | |
|---|---|
| Market cap | US$20.05m |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MDPL.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDPL.F income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MDPL.F perform over the long term?
See historical performance and comparison